Spectral Medical Inc T.EDT

Question

[megatron9191]

people were mentioning share prices going to $20-$30 if a buy out occurs, is this still possible or are we looking at $5 a share (which is still good)

[BlueJays9293]

Bad news first, yeah $20-30 is just silly. Good news, yes I think $5 USD is a reasonable and fair valuation, at an absolute mortality benefit of 12%.  Do you're own currency exchange rate conversion. At a 15% absolute mort benefit? I'm think more towards six. Would I cry and moan if the mort benny was 14% and we only got a Fin??? Maybe maybe not, but let's just get there

[SimonSaid]

To confirm, the baseline for mortality benefit is 10.7%, correct? How is "exceeding expecations" defined?  Mortality benefit of 15%...20%...25%...let's dream 30%; would that push the valuation to $8-$10USD a share?

[mercedesman]

The bar for the " confirmatory" trial is the same results achieved in Euphrates. I would call that a low bar given everything that has been learned in the past 5-10 years about which patients show the most benefit from PMX use guided by the EAA. However, they have never, as far as I am aware, defined " expectations " it could be the 10.7 achieved before, but this time with